Skip to main content
Clinical Trials/CTRI/2017/10/009968
CTRI/2017/10/009968
Completed
Phase 4

A Retrospective study of consecutive patients treatedwith BioMimeâ?¢ â?? Sirolimus Eluting Coronary StentSystem during a pre-defined period. - MeriT-lll A

Meril Life Sciences Pvt Ltd0 sites1,161 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: I259- Chronic ischemic heart disease, unspecified
Sponsor
Meril Life Sciences Pvt Ltd
Enrollment
1161
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 3, 2012
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Meril Life Sciences Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient is 18 Year old.
  • 2\. Patients who have been implanted with BioMime Sirolimus Eluting Coronary
  • Stent System between January\-2010 to February\-2011\.
  • 3\. The patient and/or his legal representative have provided a hospital written informed

Exclusion Criteria

  • 1\. Patients who have not been implanted with BioMime• â?? Sirolimus Eluting Coronary
  • Stent System.
  • 2\. Patients who have been implanted with BioMime• â?? Sirolimus Eluting Coronary
  • Stent System before and after January\-2010 to February\-2011

Outcomes

Primary Outcomes

Not specified

Similar Trials